| Name | Title | Contact Details |
|---|---|---|
Mark Verbeek |
Controller and Director of Information Technology | Profile |
Mary Calvano |
Senior Vice President of Marketing and Innovation | Profile |
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Prince Agri Products, Inc. is a Quincy, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Developmental Studies Center is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ChemoMetec is a worldwide leading manufacturer of automated cell counters and analysis equipment. We work closely with life science companies, research institutes, universities, hospitals, specialist clinics, and a wide range of food and beverage manuf...
Medical Care and Outcomes is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.